Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

354

Participants

Timeline

Start Date

October 25, 2022

Primary Completion Date

November 4, 2024

Study Completion Date

December 16, 2024

Conditions
GoutHyperuricemiaGout FlareTophi
Interventions
DRUG

Tigulixostat

Xanthine Oxidase Inhibitor

DRUG

Placebo

Matching placebo

Trial Locations (52)

1000

Manila Doctors Hospital, Manila

ManilaMed - Medical Center, Manila

1229

Makati Medical Center, Makati

2009

Angeles University Foundation Medical Center, Angeles

4217

Lipa Medix Medical Center, Lipa

4600

"LTD Clinic LJ", Kutaisi

8000

Davao Doctors Hospital, Davao City

10400

Phramongkutklao Hospital, Bangkok

Ramathibodi Hospital, Mahidol University, Bangkok

10700

Siriraj Hospital, Bangkoknoi

12120

Thammasat University Hospital, Khlong Luang

13850

Meridian Clinical Research, LLC, Vestal

16635

Altoona Center for Clinical Research, Duncansville

19114

Tristar Clinical Investigations, P.C., Philadelphia

20745

MD Medical Research, Oxon Hill

23219

Dominion Medical Associates, Inc., Richmond

23226

Clinical Research Partners, LLC, Richmond

23703

Meridian Clinical Research, LLC, Portsmouth

27410

Triad Clinical Trials, Greensboro

29615

Velocity Clinical Research Greenville, Greenville

30265

Vista Clinical Research, LLC, Newnan

32789

Conquest Research, LLC, Winter Park

33012

Direct Helpers Research Center, Hialeah

33134

Herco Medical and Research Center, Inc, Coral Gables

33155

Allied Biomedical Research Institute, Miami

33173

Research Institute of South Florida, Inc., Miami

33606

Clinical Research of West Florida, Inc., Tampa

33765

Clinical Research of West Florida, Inc., Clearwater

35233

University of Alabama at Birmingham, Birmingham

38654

Olive Branch Family Medical Center, Olive Branch

39150

Practice Dr. David Headley, Port Gibson

39202

Elite Clinical Research, LLC, Jackson

40213

L-MARC Research Center, Louisville

40509

Alliance for Multispecialty Research, LLC, Lexington

45377

STAT Research, Vandalia

60422

Healthcare Research Network II, LLC, Flossmoor

63042

HealthCare Research, Hazelwood

76034

PCCR Solutions, Colleyville

77099

Pioneer Research Solutions, Inc., Houston

77377

DM Clinical Research, Tomball

78240

Endeavor Clinical Trials, San Antonio

83642

Velocity Clinical Research, Meridian

84088

Velocity Clinical Research, Salt Lake City, West Jordan

84124

Highland Clinical Research, Salt Lake City

84405

South Ogden Family Medicine/CCT Research, South Ogden

89102

Healor Primary Care/CCT Research, Las Vegas

91722

Medvin Clinical Research, Covina

0102

Aleksandre Aladashvili Clinic LLC, Tbilisi

0112

LTD Israel-Georgian Medical Research Clinic Helsicore, Tbilisi

0159

"JSC Vian", Tbilisi

0160

LTD MediClub Georgia, Tbilisi

0186

LTD Multiprofile Clinic Consilium Medulla, Tbilisi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LG Chem

INDUSTRY

NCT05586958 - Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients | Biotech Hunter | Biotech Hunter